TABLE 1

Patient Characteristics and Semiquantitative Symptom Scores

ParameterGroup
IPD (n = 81)MSA (n = 15)
Age (y)62.6 ± 10.261.4 ± 9.2
Gender (M/F)50/319/6
Symptom duration (y)11.0 ± 6.43.0 ± 2.2
H&Y score ON2.4 ± 1.12.4 ± 1.1
H&Y score OFF2.8 ± 1.22.4 ± 1.1
Lateralization (L/none/R)38/13/304/11/0
Levodopa medication* (mg)690 ± 410430 ± 460
D2-agonist medication† (mg)3.12 ± 4.131.75 ± 2.14
Other drugs (n)43/813/15
Semiquantitative symptom score
    Gait disturbances2.77 ± 0.872.77 ± 0.73
    Tremor2.33 ± 1.111.60 ± 0.91
    Starting blockade2.20 ± 1.201.55 ± 0.93
    Akinesia2.51 ± 0.942.27 ± 0.88
    Cognitive performance1.49 ± 0.831.47 ± 0.74
    Ophthalmologic score1.26 ± 0.561.60 ± 0.83
    Speech and swallow1.83 ± 0.892.67 ± 0.98
    Autonomous symptoms1.15 ± 0.472.40 ± 1.07
    Postural stability1.44 ± 0.931.92 ± 1.26

  • ↵* Expressed as equivalent levodopa dose (mg).

  • ↵† Expressed as equivalent bromocriptine dose (mg).

  • Data are expressed as mean ± SD unless indicated otherwise.